Literature DB >> 22490256

Prescribing trends in veterans with posttraumatic stress disorder.

Nancy C Bernardy1, Brian C Lund, Bruce Alexander, Matthew J Friedman.   

Abstract

OBJECTIVE: The revised Department of Veterans Affairs (VA) and Department of Defense Clinical Practice Guideline for Management of Post-Traumatic Stress recommends against long-term use of benzodiazepines to manage posttraumatic stress disorder (PTSD). An analysis of recent trends among veterans receiving care for PTSD in the VA noted a decreasing proportion receiving benzodiazepines. The authors examined prescribing patterns for other medications to better understand the general context in which the changes in benzodiazepine prescribing have occurred in the VA.
METHOD: Administrative VA data from fiscal years 1999 through 2009 were used to identify veterans with PTSD using ICD-9 codes extracted from inpatient discharges and outpatient encounters. Prescribing of antidepressants, antipsychotics, and hypnotics was determined for each fiscal year using prescription drug files.
RESULTS: The proportion of veterans receiving either of the 2 Clinical Practice Guideline-recommended first-line pharmacotherapy treatments for PTSD, selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors, increased from 49.7% in 1999 to 58.9% in 2009. In addition to reduced benzodiazepine prescriptions, the overall frequency of antipsychotic use declined 6.1%, from 20.0% in 1999 to 13.9% in 2009. Nonbenzodiazepine hypnotic prescribing tripled when zolpidem was added to the VA national formulary in 2008. Buspirone prescribing decreased steadily, while prazosin prescribing expanded nearly 7-fold.
CONCLUSIONS: This work highlights several clinically important trends in prescribing over the past decade among veterans with PTSD that are generally consistent with the revised VA/Department of Defense Clinical Practice Guideline recommendations. However, the findings illustrate the limitations of administrative data and point to a need to supplement this work with a qualitative examination of PTSD prescribing from interviews with providers to better understand the strategies used to make medication management decisions. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22490256     DOI: 10.4088/JCP.11m07311

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  16 in total

1.  Insomnia Symptoms Among Female Veterans: Prevalence, Risk Factors, and the Impact on Psychosocial Functioning and Health Care Utilization.

Authors:  Kimberly A Babson; Ava C Wong; Danielle Morabito; Rachel Kimerling
Journal:  J Clin Sleep Med       Date:  2018-06-15       Impact factor: 4.062

2.  Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort.

Authors:  Kara L Jablonski; Maria D Devore; Margaret A Ryan; Emily L Streeter; Jerlyn C Tolentino; Angelica A Klinski; Nahed Bahlawan
Journal:  Prim Care Companion CNS Disord       Date:  2015-12-03

3.  Validating administrative records in post-traumatic stress disorder.

Authors:  Thad E Abrams; Mary Vaughan-Sarrazin; Terence M Keane; Kelly Richardson
Journal:  Int J Methods Psychiatr Res       Date:  2015-06-16       Impact factor: 4.035

Review 4.  Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned?

Authors:  Nancy C Bernardy; Matthew J Friedman
Journal:  Curr Psychiatry Rep       Date:  2015-04       Impact factor: 5.285

5.  Use of Guideline-Recommended Treatments for PTSD Among Community-Based Providers in Texas and Vermont: Implications for the Veterans Choice Program.

Authors:  Erin P Finley; Michael Mader; Elizabeth K Haro; Polly H Noël; Nancy Bernardy; Craig S Rosen; Mary Bollinger; Hector A Garcia; Kathleen Sherrieb; Mary Jo V Pugh
Journal:  J Behav Health Serv Res       Date:  2019-04       Impact factor: 1.505

6.  The use of second generation antipsychotics for post-traumatic stress disorder in a US Veterans Health Administration Medical Center.

Authors:  E Hermes; M Sernyak; R Rosenheck
Journal:  Epidemiol Psychiatr Sci       Date:  2013-09-05       Impact factor: 6.892

7.  Antipsychotic Medication Treatment Patterns in Adult Depression.

Authors:  Tobias Gerhard; T Scott Stroup; Christoph U Correll; Cecilia Huang; Zhiqiang Tan; Stephen Crystal; Mark Olfson
Journal:  J Clin Psychiatry       Date:  2018 Mar/Apr       Impact factor: 4.384

Review 8.  Targeting memory processes with drugs to prevent or cure PTSD.

Authors:  Christopher K Cain; George D Maynard; John H Kehne
Journal:  Expert Opin Investig Drugs       Date:  2012-07-27       Impact factor: 6.206

9.  Demographic Variation in the Use of Prazosin for Treatment of Sleep Disturbance in Combat Veterans with PTSD.

Authors:  Miriam L Rubin; Laurel A Copeland; Aimee R Kroll-Desrosiers; Alice G Knittel
Journal:  Psychopharmacol Bull       Date:  2020-05-19

10.  The Relationship of Post-traumatic Stress Disorder to End-of-life Care Received by Dying Veterans: a Secondary Data Analysis.

Authors:  Kathleen E Bickel; Richard Kennedy; Cari Levy; Kathryn L Burgio; F Amos Bailey
Journal:  J Gen Intern Med       Date:  2019-12-02       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.